A new lawsuit filed against filmmaker James Cameron and The Walt Disney Co. alleges Cameron used the facial features of a then-14-year-old actor as the basis for one of the main characters in the ...

In case you've faced some hurdles solving the clue, Bit used to make chocolate, we've got the answer for you. Crossword puzzles offer a fantastic opportunity to engage your mind, enjoy leisure time, ...

Syracuse, N.Y. – A national online used-car retailer plans to open a vehicle inspection and reconditioning center in northern Onondaga County, creating 200 full-time jobs. Carvana, which buys and ...

Microsoft says it's rolling out a revamped Windows Insider Program experience as part of the broader plans to address reliability concerns in Windows 11. For those unaware, the Windows Insider Program ...

TAMPA, Fla. (WFLA) — A popular learning program used in elementary schools, including in Hillsborough County, is now at the center of a lawsuit raising questions about how student data is collected ...

Washington — The House early Friday approved a short-term renewal until April 30 of a controversial surveillance program used by U.S. spy agencies, after Republicans revolted and refused President ...

WASHINGTON (AP) — The Senate approved a short-term renewal until April 30 of a controversial surveillance program used by U.S. spy agencies, following a chaotic, post-midnight scramble in the House to ...

AMSTERDAM, April 2 (Reuters) - Scientists and designers unveiled on Thursday a handbag made with collagen derived from Tyrannosaurus rex fossils from the U.S. ‌in a unique creation intended to ...

OpenAI will combine its web browser, ChatGPT app and Codex app into a singular desktop super app. Fidji Simo, OpenAI's CEO of Applications, will oversee the change with assistance from OpenAI ...

When tech entrepreneur Paul Conyngham found out that his dog Rosie had deadly mast-cell cancer, he was devastated. When chemotherapy and surgery didn’t work to shrink the tumors, the electrical and ...

Voyager Therapeutics has hit pause on a preclinical Alzheimer’s disease program just eight months after unveiling the asset. The neurology biotech announced back in July 2025 that it was adding a new ...